MYSZ — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-13

• Six and Three Months Ended June 30, 2026 Compared to Six and Three Months Ended June 30, 2025

• Our revenues for the three months ended June 30, 2026 amounted to $3,070,000 compared to $2,006,000 for the three months ended June 30, 2025. The increase in the three months ended June 30, 2025 from the corresponding period is primarily attributable to Amazon sales as well as inclusion of revenue g…

• Our cost of revenues expenses for the six months ended June 30, 2026 amounted to $3,551,000 compared to $1,941,000 for the six months ended June 30, 2025. The increase in comparison with the corresponding period was mainly due to increase in amounts sold in Orgad and Rotrade as well as the inclusion…

• Our research and development expenses for the six months ended June 30, 2026 amounted to $614,000 compared to $224,000 for the six months ended June 30, 2025. The increase from the corresponding period was mainly due to an increase in salaries expenses due to increased headcount and an increase in s…

• Our research and development expenses for the three months ended June 30, 2026 amounted to $375,000 compared to $142,000 for the three months ended June 30, 2025. The increase reflects continued investment in product development, AI capabilities and a larger engineering team supporting the expanded …

Text removed vs the prior filing · source: 10-Q · 2026-05-14

• Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025

• Our cost of revenues expenses for the three months ended March 31, 2026 amounted to $1,454,000 compared to $1,059,000 for the three months ended March 31, 2025. The increase in comparison with the corresponding period was mainly due to increase in amounts sold in Orgad and Rotrade.

• Our research and development expenses for the three months ended March 31, 2026 amounted to $239,000 compared to $82,000 for the three months ended March 31, 2025. The increase from the corresponding period was mainly due to an increase in salaries expenses due to increased headcount and an increase…

• Our general and administrative expenses for the three months ended March 31, 2026 amounted to $1,217,000 compared to $831,000 for the three months ended March 31, 2025. The increase was attributable to the increased in consulting expenses for investor relations as well as the as the inclusion of Per…

• As a result of the foregoing, for the three months ended March 31, 2026, our operating loss was $1,406,000 an increase of $320,000, or 33%, compared to our operating loss for the three months ended March 31, 2025 of $1,060,000.

Text added vs the prior filing · source: 10-Q · 2026-08-13

• Nasdaq has established certain standards for the continued listing of a security on the Nasdaq Capital Market. The standards for continued listing include, among other things, that the minimum bid price for the listed securities not fall below $1.00 per share for a period of 30 consecutive trading d…

• We have in the past fallen out of compliance with certain continued listing standards, including the minimum bid price requirement, although we have subsequently been able to regain compliance. No assurance, however, can be given that we will continue to be in compliance with the continued listing r…

• On July 22, 2026, the SEC approved a new Nasdaq continued listing requirement applicable to companies listed on the Nasdaq Stock Market that would require listed companies to maintain a minimum MVLS of at least $5.0 million. Under the approved rule, if a company’s MVLS remains below $5.0 million for…

• However, on July 29, 2026, the SEC notified Nasdaq that it had received notices of intention to petition for review of the approval order and, pursuant to Rule 431(e) of the SEC’s Rules of Practice, the effectiveness of the approval order was automatically stayed pending further review by the SEC. A…